PRESS RELEASE published on 07/30/2025 at 13:42, 10 months 17 days ago Inside Information / Other news releases Medincell's partner Teva increases 2025 revenue outlook for UZEDY® to $190–$200M, plans olanzapine LAI submission. Company's innovative treatments aim to improve medicine accessibility Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 07/30/2025 at 11:43, 10 months 17 days ago Medincell Releases 2024-25 Universal Registration Document Shareholders Governance Financial Report CSR Medincell
PRESS RELEASE published on 07/30/2025 at 11:38, 10 months 17 days ago Annual financial and audit reports / Terms of availability of the annual financial report Medincell announces availability of its 2024-25 Universal Registration Document, including financial and CSR reports. Innovative treatments developed aim to improve effectiveness of medicines Financial Reports Universal Registration Document CSR Innovative Treatments Medincell
BRIEF published on 05/07/2025 at 15:17, 1 year 1 month ago Medincell's Growth in Antipsychotic Treatments FDA Filing Medincell Olanzapine LAI UZEDY Antipsychotics
PRESS RELEASE published on 05/07/2025 at 15:12, 1 year 1 month ago Inside Information / Other news releases Medincell's UZEDY® sees strong sales growth in Q1 2025 with plans for Olanzapine LAI FDA submission in H2 2025. Teva's partner shares updates on key products Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 04/15/2025 at 19:53, 1 year 2 months ago Medincell increases its liquidity contract to support securities trading Liquidity Contract Rothschild Martin Maurel Actions EU Regulations Medincell
PRESS RELEASE published on 04/15/2025 at 19:48, 1 year 2 months ago Inside Information / Other news releases Medincell increases liquidity contract resources by 600,000 euros with Rothschild Martin Maurel to support higher trading volumes Liquidity Contract Rothschild Martin Maurel Amendment Medincell Trading Volumes
BRIEF published on 03/10/2025 at 11:54, 1 year 3 months ago Adage Capital exceeds 5% in MEDINCELL Euronext Paris Actions Threshold Crossing Medincell Adage Capital
BRIEF published on 02/25/2025 at 23:08, 1 year 3 months ago FDA Accepts Application for UZEDY's Use in Treating Bipolar I Disorder FDA Approval Medincell Teva Pharmaceuticals UZEDY Bipolar I Disorder
PRESS RELEASE published on 02/25/2025 at 23:03, 1 year 3 months ago Inside Information / Other news releases Teva and Medincell announce FDA acceptance of UZEDY(R) risperidone for bipolar I disorder treatment, expanding indications for this long-acting injectable antipsychotic FDA Medincell Teva UZEDY Bipolar I Disorder
Published on 06/17/2026 at 00:35, 6 hours 22 minutes ago INEO Tech Corp. Announces Closing of Private Placement and Debt Settlement
Published on 06/17/2026 at 00:28, 6 hours 29 minutes ago Apex Critical Metals Announces Filing of Technical Report on the Rift Rare Earth Project
Published on 06/17/2026 at 00:10, 6 hours 47 minutes ago Panther Minerals Announces Brokered Private Placement of up to $3,000,000
Published on 06/17/2026 at 00:00, 6 hours 57 minutes ago Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
Published on 06/16/2026 at 23:10, 7 hours 47 minutes ago Crestone Air Partners, an Air T Business, Completes Acquisition of Arena Aviation Capital, Surpassing $3.6 Billion in Assets Under Management
Published on 06/17/2026 at 05:35, 1 hour 21 minutes ago How to Build a Plug-in Balcony Solar System with Your Existing Portable Power Station
Published on 06/17/2026 at 04:15, 2 hours 41 minutes ago Frost & Sullivan White Paper Names Phancy Rise vGPU a Tier 1 Leading Platform
Published on 06/16/2026 at 19:05, 11 hours 52 minutes ago AT&S announces the Reference Share Price and the Conversion Price of the new deeply subordinated perpetual convertible bond with an early redemption option for the Company
Published on 06/16/2026 at 19:00, 11 hours 56 minutes ago R. STAHL Shareholders approve nearly all agenda items at the Annual General Meeting – Executive Board confirms annual forecast
Published on 06/16/2026 at 11:44, 19 hours 12 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 1 day 11 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
Published on 06/15/2026 at 18:32, 1 day 12 hours ago Edenred strengthens its electric charging offering with the acquisition of The Mobility House Solutions
Published on 06/15/2026 at 18:30, 1 day 12 hours ago Increase in the resources allocated to the liquidity contract with ODDO BHF
